Close Menu

The FBI is working to quell skepticism surrounding its asserton that Bruce Ivins was behind the 2001 anthrax attacks. During two press briefings, agency reps laid out how they built their case with a mix of science and detective work. First, CDC analysis of the anthrax powder showed that it was not a uniform population, and then Paul Keim's group sequenced the variants' DNA.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

A survey by Nature finds that most researchers want scientific meetings to continue virtually or with a virtual component, even after the pandemic ends.

Bloomberg reports that the B.1.351 SARS-CoV-2 viral variant could prompt the formulation of better vaccines.

Certain blood proteins may be able to distinguish COVID-19 patients who will become critically ill from those who will not, the Atlanta Journal-Constitution reports.

In Genome Biology this week: algorithm to assess regulatory features, approach to integrate multiple single-cell RNA-seq datasets, and more.